Secondary Research Sample Clauses

Secondary Research. Institution/Principal Investigator may not (i) use the Biological Samples collected under the Protocol, (ii) collect additional quantities of Biological Samples (i.e. exceeding quantities which the Protocol specifies to be collected), and/or (iii) retain any quantities of Biological Samples not used for purposes of conducting the research specified by the Protocol, for purposes of testing or use in research that is not described in the Protocol, including pharmacokinetic, pharmacogenomics, and biomarker testing and research.
Sample 1Sample 2See All (6)
Secondary Research. The review of existing information sources to use for analysis and in reference to a specific topic area.
Sample 1Sample 2
Secondary Research. Institution may not (i) use the Biological Samples collected under the Protocol, (ii) collect additional quantities of Biological Samples (i.e. exceeding quantities which the Protocol specifies to be collected), and/or (iii) retain any quantities of Biological Samples not used for purposes of conducting the research specified by the Protocol, for purposes of testing or use in research that is not described in the Protocol, including pharmacokinetic, pharmacogenomics, and 6.4 Sekundární výzkum. Zdravotnické zařízení nesmí (i) použít biologické vzorky odebrané podle protokolu, (ii) odebrat dodatečná množství biologických vzorků (tj. překročit odebírané množství specifikované protokolem) anebo (iii) si ponechat jakákoli množství biologických vzorků nepoužitých pro účely provádění výzkumu specifikovaného protokolem pro účely zkoušení nebo použití ve výzkumu, který není popsán v protokolu, včetně farmakokinetického, farmakogenomického a biomarker testing and research. biomarkerového testování a výzkumu.
Sample 1
Secondary Research. Institution may not (i) use the Biological Samples 6.4 Sekundární výzkum. Zdravotnické zařízení nesmí (i) použít biologické vzorky collected under the Protocol, (ii) collect additional quantities of Biological Samples (i.e. exceeding quantities which the Protocol specifies to be collected), and/or (iii) retain any quantities of Biological Samples not used for purposes of conducting the research specified by the Protocol, for purposes of testing or use in research that is not described in the Protocol, including pharmacokinetic, pharmacogenomics, and biomarker testing and research. odebrané podle protokolu, (ii) odebrat dodatečná množství biologických vzorků (tj. překročit odebírané množství specifikované protokolem) anebo (iii) si ponechat jakákoli množství biologických vzorků nepoužitých pro účely provádění výzkumu specifikovaného protokolem pro účely zkoušení nebo použití ve výzkumu, který není popsán v protokolu, včetně farmakokinetického, farmakogenomického a biomarkerového testování a výzkumu.
Sample 1

Related to Secondary Research

  • Technology Research Analyst Job# 1810 General Characteristics

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Secondary Systems The Developer and Connecting Transmission Owner shall each cooperate with the other in the inspection, maintenance, and testing of control or power circuits that operate below 600 volts, AC or DC, including, but not limited to, any hardware, control or protective devices, cables, conductors, electric raceways, secondary equipment panels, transducers, batteries, chargers, and voltage and current transformers that directly affect the operation of Developer or Connecting Transmission Owner’s facilities and equipment which may reasonably be expected to impact the other Party. The Developer and Connecting Transmission Owner shall each provide advance notice to the other Party, and to NYISO, before undertaking any work on such circuits, especially on electrical circuits involving circuit breaker trip and close contacts, current transformers, or potential transformers.